Jianying Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianying Yan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Chengcheng Jin
College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital
3 shared publications- Xia Xu
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, PR China
3 shared publications Xingyi Qi
College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital
3 shared publicationsXinying Liu
College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital
3 shared publicationsYanhong Xu
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, China
3 shared publicationsYing Zhang
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, China
3 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1928244
Quercetin ameliorates gestational diabetes mellitus-induced placental dysfunction by modulating the AGE-RAGE-associated oxidative and inflammatory signaling network
Background: Gestational diabetes mellitus (GDM) induces placental structural and functional disturbances associated with dysregulated AGE-RAGE/ROS signaling and inflammatory responses. Existing flavonoid-related studies merely observed changes in pathway protein levels, lacking direct experimental proof of molecular binding between candidate compounds and core receptors. This study aimed to investigate the potential involvement of RAGE in the protective effects of quercetin and to characterize the associated AGE-RAGE/ROS/NF-κB-related signaling changes in GDM placental injury. Methods: Network pharmacology was used to screen quercetin’s therapeutic targets for GDM. Molecular docking was performed using the human RAGE structure to predict the potential interaction between quercetin and RAGE, and molecular dynamics simulation was conducted to evaluate the stability of the predicted complex. A combined streptozotocin-high-fat diet GDM rat model and 30 mM high-glucose HTR-8/SVneo trophoblast injury model were constructed. FPS-ZM1 was used as a pharmacological tool to perturb RAGE-associated signaling in vitro . ROS, inflammatory cytokines, and key pathway gene and protein expression were examined to characterize the associated signaling changes. Results: Network pharmacology identified SERPINE1 (a critical regulator of placental vascular remodeling) as the core hub gene, with the AGE-RAGE pathway showing the highest enrichment score. Molecular docking and molecular dynamics simulations predicted a dynamically stable complex formed between quercetin and the ligand-binding domain of RAGE. GDM induction was associated with increased AGE accumulation, RAGE expression, ROS production, phosphorylated NF-κB p65, and SERPINE1 expression, together with an increase in Nrf2 expression, whereas quercetin treatment attenuated these alterations. Quercetin intervention also improved glucose tolerance and placental pathological changes. Conclusion: Quercetin alleviates GDM-associated placental dysfunction by improving metabolic abnormalities, oxidative imbalance, and inflammatory responses. Computational analysis suggests a potential interaction between quercetin and RAGE. These findings provide evidence that quercetin may regulate the AGE-RAGE-associated oxidative and inflammatory signaling network and improve placental homeostasis under diabetic conditions.
- 22 October 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1928244
Open AccessQuercetin ameliorates gestational diabetes mellitus-induced placental dysfunction by modulating the AGE-RAGE-associated oxidative and inflammatory signaling network
Background: Gestational diabetes mellitus (GDM) induces placental structural and functional disturbances associated with dysregulated AGE-RAGE/ROS signaling and inflammatory responses. Existing flavonoid-related studies merely observed changes in pathway protein levels, lacking direct experimental proof of molecular binding between candidate compounds and core receptors. This study aimed to investigate the potential involvement of RAGE in the protective effects of quercetin and to characterize the associated AGE-RAGE/ROS/NF-κB-related signaling changes in GDM placental injury. Methods: Network pharmacology was used to screen quercetin’s therapeutic targets for GDM. Molecular docking was performed using the human RAGE structure to predict the potential interaction between quercetin and RAGE, and molecular dynamics simulation was conducted to evaluate the stability of the predicted complex. A combined streptozotocin-high-fat diet GDM rat model and 30 mM high-glucose HTR-8/SVneo trophoblast injury model were constructed. FPS-ZM1 was used as a pharmacological tool to perturb RAGE-associated signaling in vitro . ROS, inflammatory cytokines, and key pathway gene and protein expression were examined to characterize the associated signaling changes. Results: Network pharmacology identified SERPINE1 (a critical regulator of placental vascular remodeling) as the core hub gene, with the AGE-RAGE pathway showing the highest enrichment score. Molecular docking and molecular dynamics simulations predicted a dynamically stable complex formed between quercetin and the ligand-binding domain of RAGE. GDM induction was associated with increased AGE accumulation, RAGE expression, ROS production, phosphorylated NF-κB p65, and SERPINE1 expression, together with an increase in Nrf2 expression, whereas quercetin treatment attenuated these alterations. Quercetin intervention also improved glucose tolerance and placental pathological changes. Conclusion: Quercetin alleviates GDM-associated placental dysfunction by improving metabolic abnormalities, oxidative imbalance, and inflammatory responses. Computational analysis suggests a potential interaction between quercetin and RAGE. These findings provide evidence that quercetin may regulate the AGE-RAGE-associated oxidative and inflammatory signaling network and improve placental homeostasis under diabetic conditions.
- Open Access
- 6 March 2026
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 26 (1)
Phenotypic subclassification of preeclampsia through cluster analysis of preterm birth-related factors
Preeclampsia is a multifactorial hypertensive disorder of pregnancy with heterogeneous clinical presentation and outcomes. Current classification systems inadequately capture the substantial clinical heterogeneity of preeclampsia. This study aimed to identify and characterize distinct phenotypic clusters of the disease using preterm birth-related risk factors. This retrospective cohort study included 4,132 singleton pregnancies with preeclampsia between January 2014 and December 2024. We performed unsupervised k-means clustering based on 22 preterm birth-related clinical and biochemical variables. Maternal characteristics and pregnancy outcomes were compared across the identified clusters. Random forest algorithm was employed to evaluate feature importance. Five distinct clinical clusters were identified. Cluster 1 (N = 740) exhibited metabolic-inflammatory features. Cluster 2 (N = 1090) was characterized by multiple comorbidities, including pre-gestational diabetes (39.2%) and fetal growth restriction (47.8%). Cluster 3 (N = 732) featured a heightened systemic inflammatory response. Cluster 4 (N = 707) presented with the most benign clinical features. Cluster 5 (N = 863) was distinguished by a high prevalence of uterine mechanical factors. These clusters demonstrated significant differences in preterm birth rates and other adverse pregnancy outcomes (P < 0.05). Random forest analysis confirmed the discriminative power of the selected variables. Cluster analysis reveals five clinically distinct preeclampsia phenotypes with direct implications for preterm birth risk. This refined classification provides a foundation for investigating distinct pathophysiological mechanisms and supports the development of individualized management strategies.
- 6 March 2026
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 26 (1)
Open AccessPhenotypic subclassification of preeclampsia through cluster analysis of preterm birth-related factors
Preeclampsia is a multifactorial hypertensive disorder of pregnancy with heterogeneous clinical presentation and outcomes. Current classification systems inadequately capture the substantial clinical heterogeneity of preeclampsia. This study aimed to identify and characterize distinct phenotypic clusters of the disease using preterm birth-related risk factors. This retrospective cohort study included 4,132 singleton pregnancies with preeclampsia between January 2014 and December 2024. We performed unsupervised k-means clustering based on 22 preterm birth-related clinical and biochemical variables. Maternal characteristics and pregnancy outcomes were compared across the identified clusters. Random forest algorithm was employed to evaluate feature importance. Five distinct clinical clusters were identified. Cluster 1 (N = 740) exhibited metabolic-inflammatory features. Cluster 2 (N = 1090) was characterized by multiple comorbidities, including pre-gestational diabetes (39.2%) and fetal growth restriction (47.8%). Cluster 3 (N = 732) featured a heightened systemic inflammatory response. Cluster 4 (N = 707) presented with the most benign clinical features. Cluster 5 (N = 863) was distinguished by a high prevalence of uterine mechanical factors. These clusters demonstrated significant differences in preterm birth rates and other adverse pregnancy outcomes (P < 0.05). Random forest analysis confirmed the discriminative power of the selected variables. Cluster analysis reveals five clinically distinct preeclampsia phenotypes with direct implications for preterm birth risk. This refined classification provides a foundation for investigating distinct pathophysiological mechanisms and supports the development of individualized management strategies.
- Open Access
- 12 December 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1682007
The role of gut microbiota imbalance in preeclampsia pathogenesis: insights into FMO3-mediated inflammatory mechanisms
Background: Preeclampsia (PE) is a severe pregnancy complication linked to systemic inflammation and metabolic dysregulation. Emerging evidence suggests gut microbiota imbalance may contribute to PE pathogenesis, but the underlying mechanisms remain unclear. This study investigated whether gut dysbiosis triggers PE through flavin-containing monooxygenase 3 (FMO3)-mediated inflammatory pathways. Methods: We transplanted fecal microbiota from PE rats, healthy pregnant (HP) rats, and non-pregnant (NP) rats into antibiotic-treated dysbiotic rats, with a control group receiving normal saline (CON). Additionally, FMO3 expression was inhibited using FMO3-RNAi in parallel groups. We measured blood pressure, urine protein, FMO3 protein and mRNA expression, inflammatory markers, liver and kidney function, embryo resorption rate, and fetal weight. Gut microbiota composition was analyzed by 16S rRNA gene sequencing. The impact of interleukin-8 (IL-8) on trophoblast cell function was assessed using cell counting kit-8 (CCK-8), transwell invasion, and tube formation assays. Results: Rats receiving PE fecal microbiota transplantation (FMT) exhibited a gradual rise in blood pressure post-pregnancy, varying degrees of liver and kidney damage, markedly elevated serum inflammatory cytokines, higher fetal resorption rates, and reduced placental weights. FMO3 protein and mRNA expressions were significantly higher in the PE-FMT group. FMO3 knockdown partially improved these perinatal outcomes. Antibiotic treatment significantly decreased gut microbiota alpha and beta diversity. At the genus level, the PE-FMO3-RNAi group showed increased Escherichia-Shigella and decreased Lactobacillus compared to the PE-CON-RNAi group. In cell experiments, elevated IL-8 levels decreased the viability and invasiveness of HTR-8/SVneo cells and diminished the angiogenic potential of human umbilical vein endothelial cells (HUVECs). Conclusion: A disruption of gut microbiota could result in PE through the FMO3-driven inflammatory response, and targeting FMO3 may prove valuable in treating PE.
- 12 December 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1682007
Open AccessThe role of gut microbiota imbalance in preeclampsia pathogenesis: insights into FMO3-mediated inflammatory mechanisms
Background: Preeclampsia (PE) is a severe pregnancy complication linked to systemic inflammation and metabolic dysregulation. Emerging evidence suggests gut microbiota imbalance may contribute to PE pathogenesis, but the underlying mechanisms remain unclear. This study investigated whether gut dysbiosis triggers PE through flavin-containing monooxygenase 3 (FMO3)-mediated inflammatory pathways. Methods: We transplanted fecal microbiota from PE rats, healthy pregnant (HP) rats, and non-pregnant (NP) rats into antibiotic-treated dysbiotic rats, with a control group receiving normal saline (CON). Additionally, FMO3 expression was inhibited using FMO3-RNAi in parallel groups. We measured blood pressure, urine protein, FMO3 protein and mRNA expression, inflammatory markers, liver and kidney function, embryo resorption rate, and fetal weight. Gut microbiota composition was analyzed by 16S rRNA gene sequencing. The impact of interleukin-8 (IL-8) on trophoblast cell function was assessed using cell counting kit-8 (CCK-8), transwell invasion, and tube formation assays. Results: Rats receiving PE fecal microbiota transplantation (FMT) exhibited a gradual rise in blood pressure post-pregnancy, varying degrees of liver and kidney damage, markedly elevated serum inflammatory cytokines, higher fetal resorption rates, and reduced placental weights. FMO3 protein and mRNA expressions were significantly higher in the PE-FMT group. FMO3 knockdown partially improved these perinatal outcomes. Antibiotic treatment significantly decreased gut microbiota alpha and beta diversity. At the genus level, the PE-FMO3-RNAi group showed increased Escherichia-Shigella and decreased Lactobacillus compared to the PE-CON-RNAi group. In cell experiments, elevated IL-8 levels decreased the viability and invasiveness of HTR-8/SVneo cells and diminished the angiogenic potential of human umbilical vein endothelial cells (HUVECs). Conclusion: A disruption of gut microbiota could result in PE through the FMO3-driven inflammatory response, and targeting FMO3 may prove valuable in treating PE.
- Open Access
- 6 November 2025
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 25 (1) , 1-10
Risk stratification and prediction of emergency delivery in early-onset preeclampsia using machine learning
Early-onset preeclampsia (PE) poses significant risks for maternal and fetal outcomes, particularly when emergency delivery is required. This study aimed to develop machine learning models to predict emergency delivery within 48 h of PE diagnosis, facilitating timely clinical interventions. We analyzed a retrospective cohort of 648 singleton pregnancies diagnosed with PE at Fujian Maternal and Child Health Hospital from 2014 to 2024, with gestational ages ranging from 28 to 34 weeks. Patients were stratified into emergency delivery (≤ 48 h post-diagnosis, n = 174) and non-emergency groups (n = 474). Feature selection was performed via univariate analysis, collinearity testing, and logistic regression, yielding 16 predictors. Eight machine learning models (logistic regression, naïve Bayes, XGBoost, LightGBM, SVM, GBDT, MLP, elastic net) were trained and evaluated for discriminative power and calibration. SHAP analysis was employed to interpret model predictions. XGBoost demonstrated superior performance (testing AUROC: 0.908) with excellent calibration, while GBDT achieved high AUROC (0.931) but poorer calibration. SHAP analysis identified CRP, D-dimer, and hypoproteinemia as the most influential predictors. Machine learning models effectively predict emergency delivery in early-onset PE using clinically interpretable features. Integration into obstetric practice may enhance risk stratification, though prospective validation is warranted.
- 6 November 2025
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 25 (1) , 1-10
Open AccessRisk stratification and prediction of emergency delivery in early-onset preeclampsia using machine learning
Early-onset preeclampsia (PE) poses significant risks for maternal and fetal outcomes, particularly when emergency delivery is required. This study aimed to develop machine learning models to predict emergency delivery within 48 h of PE diagnosis, facilitating timely clinical interventions. We analyzed a retrospective cohort of 648 singleton pregnancies diagnosed with PE at Fujian Maternal and Child Health Hospital from 2014 to 2024, with gestational ages ranging from 28 to 34 weeks. Patients were stratified into emergency delivery (≤ 48 h post-diagnosis, n = 174) and non-emergency groups (n = 474). Feature selection was performed via univariate analysis, collinearity testing, and logistic regression, yielding 16 predictors. Eight machine learning models (logistic regression, naïve Bayes, XGBoost, LightGBM, SVM, GBDT, MLP, elastic net) were trained and evaluated for discriminative power and calibration. SHAP analysis was employed to interpret model predictions. XGBoost demonstrated superior performance (testing AUROC: 0.908) with excellent calibration, while GBDT achieved high AUROC (0.931) but poorer calibration. SHAP analysis identified CRP, D-dimer, and hypoproteinemia as the most influential predictors. Machine learning models effectively predict emergency delivery in early-onset PE using clinically interpretable features. Integration into obstetric practice may enhance risk stratification, though prospective validation is warranted.
- Open Access
- 1 March 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 923-935
Endometriosis Severity and Risk of Preeclampsia: A Combined Mendelian Randomization and Observational Study
Purpose: Endometriosis has been hypothesized to increase the risk of preeclampsia (PE) and eclampsia, although the exact mechanism of this relationship is not clear. This study aimed to further explore the potential association between endometriosis and PE/eclampsia through Mendelian randomization (MR) and confirm these findings in a retrospective cohort study. Methods: A two-sample MR study was performed using genetic variants associated with endometriosis from the Finnish database, with outcome data for PE and eclampsia from the UK Biobank. Subgroup analyses were conducted based on endometriosis severity (American society of reproductive Medicine (ASRM) stages I–II and III–IV) and anatomical location (uterus, ovary, deep infiltrating endometriosis). Additionally, a retrospective cohort study was conducted to further assess the association, adjusting for confounding factors such as age, Body Mass Index (BMI), dysmenorrhea, history of uterine surgery, and adenomyosis. Multivariate logistic regression was used to analyze the risk of PE/eclampsia based on endometriosis severity. Results: MR using the Inverse Variance Weighted method found a meaningful association between advanced endometriosis (ASRM stages III–IV) and PE/eclampsia (p = 0.008), while no significant associations were observed for lower stages or endometriosis in the uterus and ovary. In the retrospective cohort, the initial association between the revised American Fertility Society (r-AFS) score and PE/eclampsia (OR: 1.02, 95% CI: 1.01– 1.03, p < 0.001) weakened after adjusting for confounders. Significant risk factors identified included age (OR: 1.20, 95% CI: 1.10– 1.30, p < 0.001), dysmenorrhea (OR: 2.72, 95% CI: 1.31– 5.76, p = 0.008) and adenomyosis showing the strongest association (OR: 9.96, 95% CI: 5.00– 20.06, p < 0.001). Conclusion: The findings suggest a potential relationship between advanced endometriosis and the risk of PE/eclampsia. However, other clinical factors such as age, dysmenorrhea, and adenomyosis appear to contribute more significantly to the risk. Further studies are needed to confirm these findings and clarify the underlying mechanisms.
- 1 March 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 923-935
Open AccessEndometriosis Severity and Risk of Preeclampsia: A Combined Mendelian Randomization and Observational Study
Purpose: Endometriosis has been hypothesized to increase the risk of preeclampsia (PE) and eclampsia, although the exact mechanism of this relationship is not clear. This study aimed to further explore the potential association between endometriosis and PE/eclampsia through Mendelian randomization (MR) and confirm these findings in a retrospective cohort study. Methods: A two-sample MR study was performed using genetic variants associated with endometriosis from the Finnish database, with outcome data for PE and eclampsia from the UK Biobank. Subgroup analyses were conducted based on endometriosis severity (American society of reproductive Medicine (ASRM) stages I–II and III–IV) and anatomical location (uterus, ovary, deep infiltrating endometriosis). Additionally, a retrospective cohort study was conducted to further assess the association, adjusting for confounding factors such as age, Body Mass Index (BMI), dysmenorrhea, history of uterine surgery, and adenomyosis. Multivariate logistic regression was used to analyze the risk of PE/eclampsia based on endometriosis severity. Results: MR using the Inverse Variance Weighted method found a meaningful association between advanced endometriosis (ASRM stages III–IV) and PE/eclampsia (p = 0.008), while no significant associations were observed for lower stages or endometriosis in the uterus and ovary. In the retrospective cohort, the initial association between the revised American Fertility Society (r-AFS) score and PE/eclampsia (OR: 1.02, 95% CI: 1.01– 1.03, p < 0.001) weakened after adjusting for confounders. Significant risk factors identified included age (OR: 1.20, 95% CI: 1.10– 1.30, p < 0.001), dysmenorrhea (OR: 2.72, 95% CI: 1.31– 5.76, p = 0.008) and adenomyosis showing the strongest association (OR: 9.96, 95% CI: 5.00– 20.06, p < 0.001). Conclusion: The findings suggest a potential relationship between advanced endometriosis and the risk of PE/eclampsia. However, other clinical factors such as age, dysmenorrhea, and adenomyosis appear to contribute more significantly to the risk. Further studies are needed to confirm these findings and clarify the underlying mechanisms.